OVARIAN CLEAR CELL CARCINOMA
Clinical trials for OVARIAN CLEAR CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CLEAR CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN CLEAR CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a pill target Hard-to-Treat ovarian cancers?
Disease control TerminatedThis early-stage trial is testing an experimental oral drug called NXP800 in people with advanced solid tumors that have not responded to standard treatments. The study has two parts: first, to find the safest dose and schedule, and then to see if the drug shows promise in specif…
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE1 • Sponsor: Nuvectis Pharma, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Diet and drug combo aim to tame tumor side effects
Disease control TerminatedThis study tested a new drug called serabelisib combined with a diet that lowers insulin levels, with or without another chemotherapy drug, in people with advanced solid tumors that have a specific genetic change (PIK3CA mutation). The goal was to see if the diet could reduce sid…
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE1 • Sponsor: Faeth Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC